209P - Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax®) in the preoperative treatment of women with primary breast cancer (ABCSG-34)

Autor: Bjelic-Radisic, V., Singer, C.F., Pfeiler, G., Hubalek, M., Bartsch, R., Stöger, H., Pichler, A., Petru, E., Greil, R., Wette, V., Petzer, A., Sevelda, P., Egle, D., Dubsky, P., Fitzal, F., Jakesz, R., Balic, M., Frantal, S., Sölkner, L., Gnant, M.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v64-v65
Databáze: ScienceDirect